Ecovyst (ECVT) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
31 Oct, 2026Executive summary
Q4 continuing-operations sales were $172.8M; Adjusted EBITDA rose 0.9% YoY to $69.8M, and net income increased 40% to $30.0M.
FY23 sales were $691.1M vs. $820.2M and Adjusted EBITDA was $259.9M vs. $276.8M; lower sulfur-cost pass-through and reduced volume drove the sales decline.
Stable demand across most end uses; higher Advanced Silicas and Zeolyst JV sales offset lower Ecoservices pricing and sulfur-cost pass-through.
Financial highlights
FY23 net income from continuing operations was $71.2M, or $0.60 diluted EPS; Adjusted net income was $89.8M, or $0.75 Adjusted diluted EPS.
Q4 net income from continuing operations was $30.0M, or $0.26 diluted EPS; Adjusted net income was $26.1M, or $0.22 Adjusted diluted EPS.
FY23 operating income was $96.7M vs. $104.4M; Adjusted EBITDA margin was 30.7%.
Q4 Adjusted EBITDA margin was 30.9% vs. 31.1% YoY; net income margin was 17.4% vs. 11.8%.
Outlook and guidance
FY24 guidance: sales $715M–$755M, Zeolyst JV sales $145M–$165M, Adjusted EBITDA $255M–$275M, and Adjusted Free Cash Flow $85M–$105M.
FY24 capital expenditures are projected at $70M–$80M, interest expense at $45M–$55M, and the effective tax rate in the mid-20% range.
Adjusted EBITDA growth of 2% at the guidance midpoint; sulfur-cost pass-through is expected to have a largely immaterial effect on FY24 sales vs. FY23.
Outlook assumes solid regeneration-services performance, catalyst and catalyst-activation growth, and modest recovery in virgin sulfuric acid and polyethylene catalysts; hydrocracking catalysts face a timing-related off-cycle year.
Limited visibility persists for H2 demand, and recovery in virgin sulfuric acid and polyethylene catalysts remains uncertain.
Latest events from Ecovyst
- Q3 Adjusted EBITDA rose 6.4%, lifting FY2026 guidance midpoint by $9M.ECVT
Q3 2026 - Q2 2026 sales rose to $250M with strong margins and growth from strategic acquisitions.ECVT
Deutsche Bank 34th Annual Leveraged Finance Conference Presentation - Strong Q2 2026 results reflect market leadership in sulfur solutions and disciplined capital allocation.ECVT
Conference presentation - Q2 2026 sales up 42%, net income doubled, and guidance raised after Calabrian acquisition.ECVT
Q2 2026 - Q1 2025 sales reached $162 million with strong catalyst growth and stable leverage.ECVT
BMO Chemicals 2025 Conference presentation - Q1 2024 delivered higher margins, strong cash flow, and growth in sustainable catalyst markets.ECVT
2024 Wells Fargo Industrials Conference presentation - Q2 2025 sales rose, margins faced pressure, and strategic focus remains on sustainable growth.ECVT
Jefferies 2025 Industrials Conference presentation - Q3 2025 delivered robust sales and EBITDA, with post-divestiture leverage expected below 1.5x.ECVT
Citi 2025 Basic Materials Conference presentation - Q1 2026 saw robust sales and margin growth, supported by strategic expansion and strong cash flow.ECVT
BMO Chemicals 2026 Conference presentation